ArticleCancer research2019
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Open access · bronzeAbstract readMulticenter Study
In one paragraph
Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Pooled it
- High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).British journal of cancer · 2026Trial
- Trial
- The double disparity: Vitamin D deficiency and lethal prostate cancer in black men.The Journal of steroid biochemistry and molecular biology · 2025Review
- Cancer prevention: past challenges and future directions.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025Review
- The impact of diet and gut microbiota on development, treatment, and prognosis in prostate cancer.Frontiers in nutrition · 2025Review
- Intratumoral vitamin D signaling and lethal prostate cancer.Carcinogenesis · 2024Article
- Disentangling discordant vitamin D associations with prostate cancer incidence and fatality in a large, nested case-control study.International journal of epidemiology · 2024Article
- The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.Nature reviews. Urology · 2024Review
- Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data.International journal of molecular sciences · 2024Review
- Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Article
- Associations of intakes of total protein, protein from dairy sources, and dietary calcium with risks of colorectal, breast, and prostate cancer: a prospective analysis in UK Biobank.British journal of cancer · 2023Article
- Unmasking the Hidden Danger: A Decade-Long Systematic Review of Case-Control Studies on Single Occupational Risks and Prostate Cancer.Life (Basel, Switzerland) · 2023Review
- The relationship of pre-operative vitamin D and TSH levels with papillary thyroid cancer.Northern clinics of Istanbul · 2023Article
- Workplace exposure to UV radiation and strategies to minimize cancer risk.British medical bulletin · 2022Review
- Dietary Patterns and Prostate Cancer: CAPLIFE Study.Cancers · 2022Article
- Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.Cancer causes & control : CCC · 2022Article
- Article
- [Complementary medicine in uro-oncology].Der Urologe. Ausg. A · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
66 authors at 20 institutions in 13 countries.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. aurora.perez-cornago@ndph.ox.ac.uk.ORCID 0000-0002-5652-356X
Paul N ApplebyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.
Corinne E JoshuDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0002-5100-172X
Pamela L LutseyDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1572-1340
Alison M MondulDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Elizabeth A PlatzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Stephanie J WeinsteinDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.ORCID 0000-0002-3834-1535
Tracy M LayneDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.
Kathy J HelzlsouerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Kala VisvanathanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.ORCID 0000-0002-5558-2437
Petra H PeetersJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Bas Bueno-de-MesquitaDepartment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), BA Bilthoven, the Netherlands.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Marc J GunterSection of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
Konstantinos K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom.
Maria-Jose SánchezEscuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs. Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Ben SchöttkerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0002-1217-4521
Laura PernaDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Bernd HolleczekSaarland Cancer Registry, Saarbrücken, Germany.
Paul KnektNational Institute for Health and Welfare, Helsinki, Finland.
Harri RissanenNational Institute for Health and Welfare, Helsinki, Finland.
Bu B YeapThe Medical School, University of Western Australia, Perth, Australia.ORCID 0000-0002-7612-5892
Leon FlickerThe Medical School, University of Western Australia, Perth, Australia.
Osvaldo P AlmeidaThe Medical School, University of Western Australia, Perth, Australia.
Yuen Yee Elizabeth WongThe Medical School, University of Western Australia, Perth, Australia.
June M ChanDepartments of Epidemiology and Biostatistics and Urology, University of California, San Francisco, San Francisco, California.
Edward L GiovannucciDepartments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Meir J StampferDepartments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Giske UrsinCancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.ORCID 0000-0002-0835-9507
Randi E GislefossCancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Tone BjørgeCancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Haakon E MeyerDepartment of Community Medicine and Global Health, University of Oslo, Oslo, Norway.
Rune BlomhoffDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.ORCID 0000-0001-7329-3615
Shoichiro TsuganeEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Norie SawadaEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Dallas R EnglishCancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Darryl W EylesQueensland Brain Institute, University of Queensland, Queensland, Australia.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom.ORCID 0000-0001-6517-1300
Elizabeth J WilliamsonDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-6905-876X
Jonas ManjerDepartment of Translational Medicine, Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden.
Johan MalmDepartment of Translational Medicine, Clinical Chemistry, Lund University, Skåne University Hospital, Malmö, Sweden.
Martin AlmquistDepartment of Surgery, Endocrine-Sarcoma Unit, Skåne University Hospital, Lund, Sweden.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Christopher A HaimanKeck School of Medicine, University of Southern California, Los Angeles, California.
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Jeannette M SchenkCancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Cathy M TangenSWOG (Formerly the Southwest Oncology Group) Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Amanda BlackDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.
Michael B CookDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.
Wen-Yi HuangDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.ORCID 0000-0002-4440-3368
Regina G ZieglerDivision of Cancer Epidemiology and Genetics, U.S. National Cancer Institute, Bethesda, Maryland.ORCID 0000-0002-5100-9852
Richard M MartinBristol Medical School Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-7992-7719
Freddie C HamdyNuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.
Jenny L DonovanBristol Medical School Department of Population Health Sciences, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-6488-5472
David E NealNuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-6033-5086
Mathilde TouvierSorbonne Paris Cité Epidemiology and Statistics Research Center (CRESS), Nutritional Epidemiology Research Team (EREN), Inserm U1153/Inra U1125/Cnam/Paris 13 University, Bobigny, France.
Serge HercbergSorbonne Paris Cité Epidemiology and Statistics Research Center (CRESS), Nutritional Epidemiology Research Team (EREN), Inserm U1153/Inra U1125/Cnam/Paris 13 University, Bobigny, France.
Pilar GalanSorbonne Paris Cité Epidemiology and Statistics Research Center (CRESS), Nutritional Epidemiology Research Team (EREN), Inserm U1153/Inra U1125/Cnam/Paris 13 University, Bobigny, France.
Mélanie DeschasauxSorbonne Paris Cité Epidemiology and Statistics Research Center (CRESS), Nutritional Epidemiology Research Team (EREN), Inserm U1153/Inra U1125/Cnam/Paris 13 University, Bobigny, France.
Timothy J KeyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-2294-307X
Naomi E AllenClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1938-5038
National Cancer Institute · USUniversity of Oxford · GBInserm · FRJohns Hopkins University · USThe University of Western Australia · AUCancer Registry of Norway · NOGerman Cancer Research Center · DECancer Center of Hawaii · USFinnish Institute for Health and Welfare · FIHarvard University · USNuffield Orthopaedic Centre · GBPrevention Group · USSkåne University Hospital · SEBristol City Council · GBCentre international de recherche sur le cancer · FRDanish Cancer Society · DKFred Hutch Cancer Center · USHellenic Health Foundation · GRImperial College London · GBInstituto de Investigación Biosanitaria de Granada · ES
Funding
SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2MSWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6MUniversity of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2MAlpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyZIACP010195 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$22.5MPCPT and SELECT Cohorts: Core Infrastructure Support for Cancer ResearchU01CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2019 to 2023
$5.4MPCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research UM1CA182883 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TANGEN, CATHERINE M., THOMPSON, IAN M. · 2013 to 2017
$5.2MCancer Research UK 16491Cancer Research UK 19169Cancer Research UK 19170Cancer Research UK C8221/A19170NCI NIH HHS P30 CA071789NCI NIH HHS U01 CA182883NCI NIH HHS U10 CA037429NCI NIH HHS UG1 CA189974NCI NIH HHS UM1 CA182883World Health Organization 001
Abstract
Previous prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between prediagnostic concentrations of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)
Indexed as
AgedCase-Control StudiesCross-Sectional StudiesHumansMaleMiddle AgedOdds RatioProspective StudiesProstatic NeoplasmsRisk AssessmentRisk FactorsVitamin D25-hydroxyvitamin DVitamin D
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.